Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease
- PMID: 3544219
- DOI: 10.1126/science.3544219
Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease
Abstract
The formation of clusters of altered axons and dendrites surrounding extracellular deposits of amyloid filaments (neuritic plaques) is a major feature of the human brain in both aging and Alzheimer's disease. A panel of antibodies against amyloid filaments and their constituent proteins from humans with Alzheimer's disease cross-reacted with neuritic plaque and cerebrovascular amyloid deposits in five other species of aged mammals, including monkey, orangutan, polar bear, and dog. Antibodies to a 28-amino acid peptide representing the partial protein sequence of the human amyloid filaments recognized the cortical and microvascular amyloid of all of the aged mammals examined. Plaque amyloid, plaque neurites, and neuronal cell bodies in the aged animals showed no reaction with antibodies to human paired helical filaments. Thus, with age, the amyloid proteins associated with progressive cortical degeneration in Alzheimer's disease are also deposited in the brains of other mammals. Aged primates can provide biochemically relevant models for principal features of Alzheimer's disease: cerebrovascular amyloidosis and neuritic plaque formation.
Similar articles
-
Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.Am J Pathol. 1987 Dec;129(3):422-8. Am J Pathol. 1987. PMID: 3322021 Free PMC article.
-
Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains.Neurobiol Aging. 1996 Mar-Apr;17(2):249-57. doi: 10.1016/0197-4580(95)02062-4. Neurobiol Aging. 1996. PMID: 8744406
-
Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis.Brain Res Mol Brain Res. 1991 Jul;10(4):299-305. doi: 10.1016/0169-328x(91)90088-f. Brain Res Mol Brain Res. 1991. PMID: 1656157
-
Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease.Neurobiol Aging. 1989 Sep-Oct;10(5):387-95. doi: 10.1016/0197-4580(89)90072-9. Neurobiol Aging. 1989. PMID: 2510035 Review.
-
Altered structural proteins in plaques and tangles: what do they tell us about the biology of Alzheimer's disease?Neurobiol Aging. 1986 Nov-Dec;7(6):425-32. doi: 10.1016/0197-4580(86)90055-2. Neurobiol Aging. 1986. PMID: 3104810 Review.
Cited by
-
CHRNA7 Polymorphisms and Dementia Risk: Interactions with Apolipoprotein ε4 and Cigarette Smoking.Sci Rep. 2016 Jun 2;6:27231. doi: 10.1038/srep27231. Sci Rep. 2016. PMID: 27249957 Free PMC article.
-
AβPP processing results in greater toxicity per amount of Aβ1-42 than individually expressed and secreted Aβ1-42 in Drosophila melanogaster.Biol Open. 2016 Aug 15;5(8):1030-9. doi: 10.1242/bio.017194. Biol Open. 2016. PMID: 27387531 Free PMC article.
-
Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain.Acta Neuropathol. 1989;77(5):535-46. doi: 10.1007/BF00687256. Acta Neuropathol. 1989. PMID: 2524150
-
Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer's disease.Experientia. 1990 Jan 15;46(1):94-7. doi: 10.1007/BF01955428. Experientia. 1990. PMID: 1688809
-
Cerebral amyloid angiopathy with attenuation of the white matter on CT scans: subcortical arteriosclerotic encephalopathy (Binswanger) in a normotensive patient.J Neurol. 1988 Sep;235(7):435-7. doi: 10.1007/BF00314490. J Neurol. 1988. PMID: 3221249
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical